Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Haferkamp

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
Journal of Medical Internet Research|February 2, 2021
Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model StudyMax Schmitt, Roman Christoph Maron, Achim Hekler, et al.
Nature Communications|February 11, 2018
Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanomaMelanie Werner-Klein, Sebastian Scheitler, Martin Hoffmann, et al.
Cancers|November 26, 2022
Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg RegistryMaximilian Haist, Henner Stege, Berenice Mareen Lang, et al.
Nature Cancer|February 16, 2023
Reciprocal interactions between innate immune cells and astrocytes facilitate neuroinflammation and brain metastasis via lipocalin-2Omer Adler, Yael Zait, Noam Cohen, et al.
EMBO Molecular Medicine|December 5, 2025
Micrometastasis-derived models enable drug testing for early-stage, high-risk melanoma patientsKathrin Weidele, Christian Werno, Steffi Treitschke, et al.
Lancet (London, England)|July 14, 2023
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trialJürgen C Becker, Selma Ugurel, Ulrike Leiter, et al.
Journal of Medical Internet Research|September 11, 2020
Artificial Intelligence and Its Effect on Dermatologists' Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey StudyRoman C Maron, Jochen S Utikal, Achim Hekler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2026
MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 InhibitionMax Schlaak, Carolina Cimminiello, Jacopo Pigozzo, et al.
Cancer Immunology Research|July 16, 2020
CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti-PD-L1 TreatmentValentina Volpin, Tillmann Michels, Antonio Sorrentino, et al.
Immunology|March 6, 2024
Comparison of the oncolytic activity of a replication-competent and a replication-deficient herpes simplex virus 1Georg Lindner, Annika Walter, Clara L Magnus, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
Journal of Medical Internet Research|February 2, 2021
Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model StudyMax Schmitt, Roman Christoph Maron, Achim Hekler, et al.
Nature Communications|February 11, 2018
Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanomaMelanie Werner-Klein, Sebastian Scheitler, Martin Hoffmann, et al.
Cancers|November 26, 2022
Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg RegistryMaximilian Haist, Henner Stege, Berenice Mareen Lang, et al.
Nature Cancer|February 16, 2023
Reciprocal interactions between innate immune cells and astrocytes facilitate neuroinflammation and brain metastasis via lipocalin-2Omer Adler, Yael Zait, Noam Cohen, et al.
EMBO Molecular Medicine|December 5, 2025
Micrometastasis-derived models enable drug testing for early-stage, high-risk melanoma patientsKathrin Weidele, Christian Werno, Steffi Treitschke, et al.
Lancet (London, England)|July 14, 2023
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trialJürgen C Becker, Selma Ugurel, Ulrike Leiter, et al.
Journal of Medical Internet Research|September 11, 2020
Artificial Intelligence and Its Effect on Dermatologists' Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey StudyRoman C Maron, Jochen S Utikal, Achim Hekler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2026
MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 InhibitionMax Schlaak, Carolina Cimminiello, Jacopo Pigozzo, et al.
Cancer Immunology Research|July 16, 2020
CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti-PD-L1 TreatmentValentina Volpin, Tillmann Michels, Antonio Sorrentino, et al.
Immunology|March 6, 2024
Comparison of the oncolytic activity of a replication-competent and a replication-deficient herpes simplex virus 1Georg Lindner, Annika Walter, Clara L Magnus, et al.
Pageof 15